020 7042 5800 - 9:00am to 5:00pm - Mon to Fri

Clinical Trials For Healthy Volunteers

Recruiting healthy adults

£2,650
C23026 (Cohort 4)
Age:
18-45
London Bridge

We are conducting a clinical trial for an experimental drug that could be used to treat people with alcohol addiction.

Recruiting healthy adults

Payment:
£2,650
Age:
18-45
Study:
C23026 (Cohort 4)

We are conducting a clinical trial for an experimental drug that could be used to treat people with alcohol addiction.

Recruiting healthy adults

£4,600
C23043
Age:
18-40
London Bridge

We are conducting a clinical trial for an investigational drug that could be used to treat people with Paroxysmal Nocturnal Hemoglobinuria (PNH).

Recruiting healthy adults

Payment:
£4,600
Age:
18-40
Study:
C23043

We are conducting a clinical trial for an investigational drug that could be used to treat people with Paroxysmal Nocturnal Hemoglobinuria (PNH).

Clinical Trials For Patients

Recruiting adults with Alpha-1 Antitrypsin Deficiency (AATD).

£2,550
Age:
18-70
London Bridge
C23018

We are conducting a study for adults with genetically diagnosed alpha-1 antitrypsin deficiency (AATD).

Recruiting adults with Alpha-1 Antitrypsin Deficiency (AATD).

Payment:
£2,550
Age:
18-70
Study:
C23018
London Bridge

We are conducting a study for adults with genetically diagnosed alpha-1 antitrypsin deficiency (AATD).

Recruiting adults with High Blood Pressure

£1,233
Age:
18 years and older
London Bridge
C24009

We are conducting a clinical trial for a potential new medicine that could be used to treat people with hypertension (high blood pressure).

Recruiting adults with High Blood Pressure

Payment:
£1,233
Age:
18 years and older
Study:
C24009
London Bridge

We are conducting a clinical trial for a potential new medicine that could be used to treat people with hypertension (high blood pressure).

Recruiting adults with Heterozygous Familial Hypercholesterolemia (HeFH) or premature Coronary Artery Disease (CAD)

£2,450
Age:
18 to 65
London Bridge
C23021

The Heart-2 study is evaluating the safety and tolerability of a study drug in addition to seeing if it may lower cholesterol in people with HeFH or CAD.

Recruiting adults with Heterozygous Familial Hypercholesterolemia (HeFH) or premature Coronary Artery Disease (CAD)

Payment:
£2,450
Age:
18 to 65
Study:
C23021
London Bridge

The Heart-2 study is evaluating the safety and tolerability of a study drug in addition to seeing if it may lower cholesterol in people with HeFH or CAD.

Recruiting People with Von Willebrand Disease (VWD)

£968
Age:
16 and above
London Bridge
C23024

We are conducting a study for people with Von Willebrand Disease (VWD).

Recruiting People with Von Willebrand Disease (VWD)

Payment:
£968
Age:
16 and above
Study:
C23024
London Bridge

We are conducting a study for people with Von Willebrand Disease (VWD).

Recruiting adults with High Cholesterol

£2,400
Age:
18 to 70
London Bridge
C24018

In this clinical trial we are recruiting people with cholesterol that is too high (not at the medically recommended goal).

Recruiting adults with High Cholesterol

Payment:
£2,400
Age:
18 to 70
Study:
C24018
London Bridge

In this clinical trial we are recruiting people with cholesterol that is too high (not at the medically recommended goal).

Recruiting people with High Blood Pressure (Hypertension)

£136 plus £20 travel
Age:
18-65
London Bridge
C19030 (HBP)

We are looking for people with High Blood Pressure (Hypertension) to attend a medical checkup.

Recruiting people with High Blood Pressure (Hypertension)

Payment:
£136 plus £20 travel
Age:
18-65
Study:
C19030 (HBP)
London Bridge

We are looking for people with High Blood Pressure (Hypertension) to attend a medical checkup.

Recruiting people with Glanzmann thrombasthenia

£1,830
Age:
18-65
London Bridge
C22003 (Part B)

Help us improve current treatments available to patients with Glanzmann thrombasthenia.

Recruiting people with Glanzmann thrombasthenia

Payment:
£1,830
Age:
18-65
Study:
C22003 (Part B)
London Bridge

Help us improve current treatments available to patients with Glanzmann thrombasthenia.

Recruiting adults with Alpha-1 Antitrypsin Deficiency (AATD)

£150
Age:
18-70
London Bridge
C23017 (Cohort 1)

We are conducting a study for participants with genetically diagnosed alpha-1 antitrypsin deficiency (AATD).

Recruiting adults with Alpha-1 Antitrypsin Deficiency (AATD)

Payment:
£150
Age:
18-70
Study:
C23017 (Cohort 1)
London Bridge

We are conducting a study for participants with genetically diagnosed alpha-1 antitrypsin deficiency (AATD).